Del Carmen Jeffrey

CIK 00018164771 companyCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001816477

Recent Transactions

50 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08+8,039→ 12,001 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08−2,492→ 9,509 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-08−8,039→ 1,045,513 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$4.21/sh+10,983→ 14,945 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-26$23.33/sh−10,983→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-26+10,983→ 1,053,552 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−5,603→ 1,064,535 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21−1,641→ 3,962 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+5,603→ 5,603 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+106,873→ 1,037,881 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+32,257→ 1,070,138 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-03-03$22.89/sh−30,423→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-02-14+10,667→ 33,548 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-02-14−3,125→ 30,423 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−10,667→ 931,008 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-12-27+8,667→ 26,720 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-12-27−3,839→ 22,881 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−8,667→ 941,675 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-12-09−2,355→ 18,053 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−8,039→ 950,342 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-12-09+8,039→ 20,408 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21−16,809→ 958,381 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21−137,553→ 941,572 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-09$2.86/sh+30,000→ 42,369 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-08-09−30,000→ 804,019 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-09$18.42/sh−30,000→ 12,369 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-09$18.44/sh−6,058→ 12,369 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-06-07$16.07/sh−7,541→ 18,427 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−10,667→ 834,019 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-02-15−3,125→ 25,968 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-02-15+10,667→ 29,093 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−8,666→ 844,686 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-27+8,666→ 22,265 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-27−3,839→ 18,426 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-08+24,117→ 853,352 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+167,918→ 829,235 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-06-27+10,000→ 17,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-06-27−10,000→ 661,317 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-06-27−3,942→ 13,599 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-03-29$16.70/sh−20,983→ 7,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-03-29−20,983→ 690,334 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-03-29$16.69/sh−19,017→ 7,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-03-29$4.21/sh+19,017→ 26,558 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-03-29−19,017→ 671,317 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-03-29$2.24/sh+20,983→ 28,524 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15−10,666→ 711,317 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-02-15−3,125→ 7,541 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-02-15+10,666→ 10,666 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-27+26,000→ 721,983 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-12-27+88,000→ 695,983 total

Companies

CATALYST PHARMACEUTICALS, INC.
Chief Commercial Officer
$CPRX

Recent Filings

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov